Evidence map›Paper›PMID 30519672›Full record

ArticleJournal of the Endocrine Society2018

Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism.

Ella Kohva, Hanna Huopio, Matti Hero, Päivi J Miettinen, Kirsi Vaaralahti, Virpi Sidoroff, Jorma Toppari, Taneli Raivio

Open access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. A Current Perspective on Delayed Puberty and Its ManagementJournal of clinical research in pediatric endocrinology · 2024
    Review
  5. Review
  6. Article
  7. Replacement of Male Mini-Puberty.Journal of the Endocrine Society · 2019
    Article
  8. Article
  9. Hypogonadism and Cryptorchidism.Frontiers in endocrinology · 2019
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ella KohvaUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0001-5654-6772
Hanna HuopioUniversity of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
Matti HeroUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-9843-5082
Päivi J MiettinenUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-5184-9616
Kirsi VaaralahtiUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Virpi SidoroffNorth Karelia Central Hospital, Joensuu, Finland.ORCID 0000-0001-9561-5080
Jorma ToppariInstitute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku and Department of Pediatrics, Turku University Hospital, Turku, Finland.ORCID 0000-0003-2228-334X
Taneli RaivioUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0001-5385-434X
University of Helsinki · FINorth Karelia Central Hospital · FIUniversity of Eastern Finland · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextRecombinant human FSH (r-hFSH), given to prepubertal boys with hypogonadotropic hypogonadism (HH), may induce Sertoli cell proliferation and thereby increase sperm-producing capacity later in life.

objectiveTo evaluate the effects of r-hFSH, human chorionic gonadotropin (hCG), and testosterone (T) in such patients. DESIGN AND

settingRetrospective review in three tertiary centers in Finland between 2006 and 2016. PATIENTS: Five boys:

interventionsTwo boys received r-hFSH (6 to 7 months) followed by r-hFSH plus hCG (33 to 34 months); one received T (6 months), then r-hFSH plus T (29 months) followed by hCG (25 months); two received T (3 months) followed by r-hFSH (7 months) or r-hFSH plus T (8 months).

main outcome measuresTV, inhibin B, anti-Müllerian hormone, T, puberty, sperm count.

resultsr-hFSH doubled TV (from a mean ± SD of 0.9 ± 0.9 mL to 1.9 ± 1.7 mL;

conclusionsSpermatogenesis can be induced with gonadotropins even in boys with HH who have extremely small testes, and despite low-dose T treatment given in early puberty. Induction of puberty with gonadotropins allows preservation of fertility.

Indexed as

FSHhypogonadotropic hypogonadisminhibin Bprepubertal

Identifiers

PMID30519672
PMCPMC6270974
OpenAlexW2896562031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.